[Scientific Statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension(1) Role of salt in hypertension and cardiovascular diseases

Hypertension Research

Volumn 36, Issue 12, 2013, Pages 1009-1019

  Ando, Katsuyuki ^a   Kawarazaki, Hiroo ^b   Miura, Katsuyuki ^c   Matsuura, Hideo ^d   Watanabe, Yoshihiko ^e   Yoshita, Katsushi ^f   Kawamura, Minoru ^g   Kusaka, Miho ^h   Kai, Hisashi ⁱ   Tsuchihashi, Takuya ^j   Kawano, Yuhei ^k  

^a UNIVERSITY OF TOKYO   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d Saiseikai Kure Hospital   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f Osaka Prefecture University   (Japan)

^g Iwate Prefectural Central Hospital   (Japan)

^h Kusaka Clinic   (Japan)

ⁱ KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^k NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

more..

Author keywords

blood pressure; heart disease; kidney disease; sodium chloride; stroke

Indexed keywords

ALBUMIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; CALCIUM; CHLORTALIDONE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; NITRIC OXIDE; POTASSIUM; PROTEIN; RAMIPRIL; TELMISARTAN; TRIACYLGLYCEROL;

ARTERIOSCLEROSIS; BODY FLUID; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; EXERCISE; FRUIT; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; JAPAN; KIDNEY FAILURE; LIPID METABOLISM; LOW FAT DIET; MENTAL STRESS; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MICROALBUMINURIA; MORBIDITY; OBESITY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SODIUM RESTRICTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; VEGETABLE; WEIGHT REDUCTION;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET; DIET, SODIUM-RESTRICTED; EXERCISE; FOOD HABITS; HUMANS; HYPERTENSION; JAPAN; KIDNEY; LIFE STYLE; SOCIETIES, MEDICAL; SODIUM; SODIUM, DIETARY; STRESS, PHYSIOLOGICAL;

EID: 84890050215     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.102     Document Type: Review

References (116)

1. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale of salt restriction target level for the management of hypertension. Hypertens Res 2007; 30: 879-886
2. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2009). Hypertens Res. 2009; 32: 3-107
3. Eaton SB, Eaton SB 3rd, Konner MJ, Shostak M. An evolutionary perspective enhances understanding of human nutritional requirements. J Nutr 1996; 126: 1732-1740
4. Ritz E, Mehls O. Salt restriction in kidney disease-A missed therapeutic opportunity? Pediatr Nephrol 2009; 24: 9-17
5. Laragh JH. Lewis K. Dahl Memorial Lecture. The renin system and four lines of hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack. Hypertension 1992; 20: 267-279
6. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Am J Hypertens 2012; 25: 1-15
7. FujitaT.Salt and Hypertension. Nihon Igaku Shuppan, Tokyo, 1984, in Japanese
8. Dahl LK, Love RA. Evidence for relationship between sodium (chloride) intake and human essential hypertension. Arch Intern Med 1954; 94: 525-531
9. INTERSALT Cooperative Research Group. Intersalt: An international study of electrolyte excretion and blood pressure: Results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-328
10. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and lowsodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64: 193-198
11. Fujita T, Ando K, Ogata E. Systemic and regional hemodynamics in patients with saltsensitive hypertension. Hypertension 1990; 16: 235-244
12. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovský J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA. European Project on Genes in Hypertension (EPOGH) Investigators. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011; 305: 1777-1785
13. O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306: 2229-2238
14. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. JAMA 1992; 267: 1213-1220
15. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA., TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839-846
16. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10
17. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997; 157: 657-667
18. Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, Appel LJ, Kumanyika S, Farmer D, Elam J, Wilson AC, Applegate WB. TONE Cooperative Reaserch Group. Predictors and mediators of successful long-Term withdrawal from antihypertensive medications. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med 1999; 8: 228-236
19. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: A metaanalysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16: 761-770
20. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-Analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597
21. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial. Hypertension 2009; 54: 475-481
22. Kawano Y, Abe H, Kojima S, Yoshimi H, Sanai T, Kimura G, Matsuoka H. Different effects of alcohol and salt on 24-hour blood pressure and heart rate in hypertensive patients. Hypertens Res 1996; 19: 255-261
23. Uzu T, Ishikawa K, Fujii K, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859-1862
24. Luft FC, Rankin LI, Bloch R, Weyman AE, Willis LR, Murray RH, Grim CE, Weinberger MH. Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979; 60: 697-706
25. Guyton AC. Arterial Pressure and Hypertension. WB Saunders Company, Philadelphia, 1980: Pp. 395-402
26. Takahashi H, Yoshika M, Komiyama Y, Nishimura M. The central mechanism underlying hypertension: A review of the roles of sodium ions, epithelial sodium channels, the renin-Angiotensin-Aldosterone system, oxidative stress and endogenous digitalis in the brain. Hypertens Res 2011; 34: 1147-1160
27. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360-367
28. Kawano Y, Ferrario CM. Neurohumoral characteristics of cardiovascular response due to intraventricular hypertonic NaCl. Am J Physiol Heart Circ Physiol 1984; 247: H422-H428
29. Kawano Y, Sudo RT, Ferrario CM. Effects of chronic intraventricular sodium on blood pressure and fluid balance. Hypertension 1991; 17: 28-35
30. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321: 580-585
31. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Nishio Y, Maegawa H, Koya D, Haneda M, Kashiwagi A. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens 2006; 24: 1627-1632
32. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, Whelton PK, He J. GenSalt Collaborative Research Group. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: A dietary intervention study. Lancet 2009; 373: 829-835
33. Rocchini AP. Obesity hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis 2000; 10: 287-294
34. Ando K, Fujita M. Reactive oxygen species and the central nervous system in saltsensitive hypertension: Possible relationship to obesity-induced hypertension. Clin Exp Pharmacol Physiol 2012; 39: 111-116
35. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004; 43: 358-363
36. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004; 101: 10302-10307
37. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. DASH Collaborate Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117-1124
38. Akita S, Sacks FM, Svetkey LP, Conlin PR, Kimura G. Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension 2003; 42: 8-13
39. Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 1984; 6: 184-192
40. Meneely GR, Battarbee HD. Sodium and potassium. Nutr Rev. 1976; 34: 225-235
41. Fujita T, Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int 1983; 24: 731-739
42. Ando K, Matsui H, Fujita M, Fujita T. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: Possible role of its antioxidant action. Curr Vasc Pharmacol 2010; 8: 59-63
43. Resnick LM, Mü ller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105: 649-654
44. Saito K, Sano H, Furuta Y, Fukuzaki H. Effect of oral calcium on blood pressure response in salt-loaded borderline hypertensive patients. Hypertension 1989; 13: 219-226
45. Ando K, Sato Y, Ono A, Takahashi K, Shimosawa T, Ogata E, Fujita T. Antihypertensive effect of dietary calcium loading in angiotensin II-salt rats. Am J Physiol Regul Integr Comp Physiol 1991; 261: R1070-R1074
46. Kiyonaga A, Arakawa K, Tanaka H, Shindo M. Blood pressure and hormonal responses to aerobic exercise. Hypertension 1985; 7: 125-131
47. Sakai T, Ideishi M, Miura S, Maeda H, Tashiro E, Koga M, Kinoshita A, Sasaguri M, Tanaka H, Shindo M, Arakawa K. Mild exercise activates renal dopamine system in mild hypertensives. J Hum Hypertens 1998; 12: 355-362
48. Anderson DE. Interactions of stress, salt, and blood pressure. Annu Rev Physiol 1984; 46: 143-153
49. Light KC, Koepke JP, Obrist PA, Willis PW 4th. Psychological stress induces sodium and fluid retention in men at high risk for hypertension. Science 1983; 220: 429-431
50. Sasaki N. The relationship of salt intake to hypertension in Japanese. Geriatrics 1964; 19: 735-744
51. Tomonari T, Fukuda M, Miura T, Mizuno M, Wakamatsu TY, Ichikawa T, Miyagi S, Shirasawa Y, Ito A, Yoshida A, Omori T, Kimura G. Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in Japan. J Am Soc Hypertens 2011; 5: 456-462
52. Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke 2004; 35: 1543-1547
53. Umesawa M, Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A. JACC Study Group. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: The Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr 2008; 88: 195-202
54. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001; 357: 848-851
55. Kagan A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985; 16: 390-396
56. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006; 119: 275. e7-275.e14
57. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995; 25: 1144-1152
58. Strazzullo P, D'Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: Metaanalysis of prospective studies. BMJ 2009; 339: B4567
59. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027-2034
60. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stroke 1992; 23: 1237-1241
61. Geleijnse JM, Witteman JC, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: The Rotterdam study. Eur J Epidemiol 2007; 22: 763-770
62. Larsson SC, Virtanen MJ, Mars M, Mannisto S, Pietinen P, Albanes D, Virtamo J. Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers. Arch Intern Med 2008; 168: 459-465
63. He FJ, Appel LJ, Cappuccio FP, de Wardener HE, MacGregor GA. Does reducing salt intake increase cardiovascular mortality? Kidney Int 2011; 80: 696-698
64. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23: 363-384
65. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956
66. Du Cailar G, Ribstein J, Daures JP, Mimran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol Heart Circ Physiol 1992; 263: H177-H181
67. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36-37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041-1050
68. Ferrara LA, de Simone G, Pasanisi F, Mancini M, Mancini M. Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension 1984; 6: 755-759
69. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-Term nonpharmacological treatment with sodium restriction in mild-To-moderate essential hypertension. Circulation 1994; 89: 1023-1031
70. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB. Sodium and potassium intake and mortality among US adults: Prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011; 171: 1183-1191
71. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104
72. Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, Mak S, Allard JP, Newton GE. A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: A prospective follow-up study1-3. Am J Clin Nutr 2011; 93: 332-337
73. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: Is sodium an old enemy or a new friend? Clin Sci 2008; 114: 221-230
74. Krikken JA, Laverman GD, Navis G. Benefits of dietary sodium restriction in the management of chronic kidney disease. Cur Opin Nephrol Hypertens 2009; 18: 531-538
75. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 2008; 19: 999-1007
76. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 2005; 46: 308-312
77. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994; 23: 195-199
78. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54: 482-488
79. Verhave JC, Hillege HL, Burgerhof GM, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE. PREVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004; 256: 324-330
80. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Takasaki S, Kubota I. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata study. Kidney Int 2006; 70: 751-756
81. Krikken JA, Lely AT, Bakker SJL, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007; 71: 260-265
82. Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012; 23: 165-173
83. Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 1998; 13: 1682-1685
84. Lin J, Hu FB, Curhan GC. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 2010; 5: 836-843
85. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH. FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34: 861-866
86. WHO; World Heart Federation; World Stroke Organization. Global atlas on cardiovascular disease prevention and control: Policies, strategies and interventions. WHO 2011
87. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: The National Health and Nutrition Examination Survey (NHANES I). Lancet 1998; 351: 781-785
88. Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011; 34: 703-709
89. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: Cohort study. BMJ 1997; 315: 722-729
90. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ 2007; 334: 885-888
91. Cohen HW, Hailpern SM, Alderman MH. Sodium intake andmortality follow-up in the third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med 2008; 23: 1297-1302
92. Alderman MH. Presidential Address: 21st Scientific Meeting of the International Society of Hypertension: Dietary sodium and cardiovascular disease: The 'J'-shaped relation. J Hypertens 2007; 25: 903-907
93. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: A meta-Analysis of randomized controlled trials (Cochrane Review). Am J Hypertens 2011; 8: 843-853
94. He F, MacGregor GA. Salt reduction lowers cardiovascular risk: Meta-Analysis of outcome trials. Lancet 2011; 378: 380-382
95. Morgan T, Adam W, Gillies A, Wilson M, Morgan G, Carney S. Hypertension treated by salt restriction. Lancet 1978; 1: 227-230
96. Garg R, Williams GH, Hurwitz S, Brown NJ, Hopkins PN, Adler GK. Low-salt diet increases insulin resistance in healthy subjects. Metabolism 2001; 60: 965-968
97. Volpe M, Muller FB, Trimarco B. Transient enhancement of sympathetic nervous system activity by long-Term restriction of sodium intake. Circulation 1985; 72: 47-52
98. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short-And longterm neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002; 106: 1957-1961
99. Xu J, Carretero OA, Liao TD, Peng H, Shesely EG, Xu J, Liu TS, Yang JJ, Reudelhuber TL, Yang XP. Local angiotensin II aggravates cardiac remodeling in hypertension. Am J Physiol Heart Circ Physiol 2010; 299: H1328-H1338
100. van Kats JP, Methot D, Paradis P, Silversides DW, Reudelhuber TL. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice: Direct and indirect effects of angiotensin II on the heart. J Biol Chem 2001; 276: 44012-44017
101. Shibata S, Mu S-Y, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, Fujita T. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 2011; 121: 3233-3243
102. Beckmann SL, Os I, Kjeldsen SE, Eide IK, Westheim AS, Hjermann I. Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension. Am J Hypertens 1995; 8: 704-711
103. Meland E, Lerum E, Aakvaag A, Ulvik RJ, Høstmark AT. Salt restriction: Effects on lipids and insulin production in hypertensive patients. Scand J Clin Lab Invest 1997; 57: 501-506
104. Iwaoka T, Umeda T, Ohno M, Inoue J, Naomi S, Sato T, Kawakami I. The effect of low and high NaCl diets on oral glucose tolerance. Klin Wochenschr 1988; 66: 724-728
105. Sharma AM, Ruland K, Spies KP, Distler A. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991; 9: 329-335
106. Petrie JR, Morris AD, Minamisawa K, Hilditch TE, Elliott HL, Small M, McConnell J. Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 1552-1557
107. Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK, Seely EW. Insulin resistance in hypertensives: Effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001; 19: 99-105
108. Perry CG, Palmer T, Cleland SJ, Morton IJ, Salt IP, Petrie JR, Gould GW, Connell JM. Decreased insulin sensitivity during dietary sodium restriction is not mediated by effects of angiotensin II on insulin action. Clin Sci 2003; 105: 187-194
109. Townsend RR, Kappor S, McFadden CB. Salt intake and insulin sensitivity in healthy human volunteers. Clin Sci 2007; 113: 141-148
110. Foo M, Denver AE, Coppack S. Effect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects. Clin Sci 1998; 95: 157-164
111. Facchini FS, DoNascimento C, Reaven GM, Yip JW, Ni XP, Humphreys MH. Blood pressure, sodium intake, insulin resistance, and urinary nitrate excretion. Hypertension 1999; 33: 1008-1012
112. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000; 35: 864-868
113. DonoVan DS, Solomon CG, Seely EW, Williams GH, Simonson DC. Effect of sodium intake on insulin sensitivity. Am J Physiol Endocrinol Metab 1993; 264: E730-E734
114. Williams GH, Tuck MI, Sullivan JM, Dluhy RG, Hollenberg NK. Parallel adrenal and renal abnormalities in young patients with essential hypertension. Am J Med 1982; 72: 907-914
115. Nakandakare ER, Charf AM, Santos FC, Nunes VS, Ortega K, Lottenberg AM, Mion D Jr, Nakano T, Nakajima K, D'Amico EA, Catanozi S, Passarelli M, Quintäo EC. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients. Atherosclerosis 2008; 200: 410-416
116. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: Modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101: 856-861